<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Regulatory Blog and News</title>
<link>http://www.pharmstatus.com/regulatory/blog.html</link>
<description>Links, guidelines, updates about regulatory writing for FDA, EU, and ICH documents.</description>
<language>en-US</language>
<copyright>Copyright 2009</copyright>
<lastBuildDate>Sat, 28 Feb 2009 16:01:15 -0800</lastBuildDate>
<pubDate>Sat, 28 Feb 2009 16:01:15 -0800</pubDate>
<generator>http://thingamablog.sf.net</generator>
<docs>http://blogs.law.harvard.edu/tech/rss</docs>

<item>
<title>Phase I Dosing for Cancer Drugs Detailed in New ICH Guidance</title>
<description>
&lt;p&gt;&lt;a
href=&quot;http://www.fdanews.com/newsletter/article?articleId=114968&amp;amp;issueId=12438&quot;
 target=&quot;blank&quot;&gt;FDA News Source&lt;/a&gt;&lt;br /&gt;
&lt;a href=&quot;FDA-2009-D-0006-gdl.pdf&quot;&gt;FDA draft guidance&lt;/a&gt;&lt;/p&gt;
&lt;p&gt; Phase I clinical trials of cancer drugs can include
maximum...&lt;/p&gt;
</description>
<link>http://www.pharmstatus.com/regulatory/archives/02-01-2009_02-28-2009.html#39</link>
<guid>http://www.pharmstatus.com/regulatory/archives/02-01-2009_02-28-2009.html#39</guid>

<category>guidelines</category>

<pubDate>Sat, 28 Feb 2009 16:01:14 -0800</pubDate>
</item>

<item>
<title>FDA and International Serious Adverse Events Consortium Release First Data on Genetic Basis of Adverse Drug Events</title>
<description>
&lt;p&gt;&lt;a href=&quot;http://www.fda.gov/bbs/topics/NEWS/2009/NEW01956.html&quot;
target=&quot;blank&quot;&gt;FDA News Source&lt;/a&gt;&lt;br /&gt;
&lt;a href=&quot;http://www.saeconsortium.org&quot;
target=&quot;_blank&quot;&gt;International Serious Adverse Event
Consortium&lt;/a&gt;&lt;br /&gt;
&lt;a href=&quot;http://www.fda.gov/oc/initiatives/criticalpath&quot;
target=&quot;_blank&quot;&gt;FDA’s Critical Path Initiative&lt;/a&gt;&lt;/p&gt;
&lt;p&gt; The first...&lt;/p&gt;
</description>
<link>http://www.pharmstatus.com/regulatory/archives/02-01-2009_02-28-2009.html#38</link>
<guid>http://www.pharmstatus.com/regulatory/archives/02-01-2009_02-28-2009.html#38</guid>

<category>guidelines</category>

<pubDate>Sat, 28 Feb 2009 15:55:24 -0800</pubDate>
</item>

<item>
<title>FDA Takes New Regulatory Action Against Ranbaxy’s Paonta Sahib Plant in India</title>
<description>
&lt;p&gt;&lt;a href=&quot;http://www.fda.gov/bbs/topics/NEWS/2009/NEW01962.html&quot;
target=&quot;blank&quot;&gt;FDA Source&lt;/a&gt;&lt;/p&gt;
&lt;p&gt; Agency halts review of drug applications from plant due to
evidence of falsified data;...&lt;/p&gt;
</description>
<link>http://www.pharmstatus.com/regulatory/archives/02-01-2009_02-28-2009.html#37</link>
<guid>http://www.pharmstatus.com/regulatory/archives/02-01-2009_02-28-2009.html#37</guid>

<category>news</category>

<pubDate>Sat, 28 Feb 2009 15:50:49 -0800</pubDate>
</item>

<item>
<title>FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing Drugs </title>
<description>
&lt;p&gt;&lt;a href=&quot;http://www.fda.gov/bbs/topics/NEWS/2009/NEW01963.html&quot;
target=&quot;blank&quot;&gt;FDA Source&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;Agency warns against chronic use of these products to treat
gastrointestinal disorders&lt;/p&gt;
&lt;p&gt;...&lt;/p&gt;
</description>
<link>http://www.pharmstatus.com/regulatory/archives/02-01-2009_02-28-2009.html#36</link>
<guid>http://www.pharmstatus.com/regulatory/archives/02-01-2009_02-28-2009.html#36</guid>

<category>news</category>

<pubDate>Sat, 28 Feb 2009 15:48:20 -0800</pubDate>
</item>

<item>
<title>Elite Announces Drug Application Filing For Synthetic Narcotic Analgesic Accepted by FDA</title>
<description>
&lt;p&gt;&lt;a
href=&quot;http://www.globenewswire.com//newsroom/news.html?ref=rss&amp;amp;d=151126&quot;
 target=&quot;blank&quot;&gt;Globes News Wire Source&lt;/a&gt;&lt;/p&gt;
&lt;p&gt; Elite Pharmaceuticals, Inc. (&quot;Elite&quot; or the &quot;Company&quot;)
(AMEX:ELI) in collaboration with ThePharmaNetwork,...&lt;/p&gt;
</description>
<link>http://www.pharmstatus.com/regulatory/archives/10-01-2008_10-31-2008.html#35</link>
<guid>http://www.pharmstatus.com/regulatory/archives/10-01-2008_10-31-2008.html#35</guid>

<category>news</category>

<pubDate>Thu, 02 Oct 2008 14:10:15 -0700</pubDate>
</item>

<item>
<title> FDA Offers Advice on End of Phase IIa Meetings </title>
<description>
&lt;p&gt;&lt;a
href=&quot;http://www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2008-D-0514-gdl.pdf&quot;
 target=&quot;blank&quot;&gt;FDA Source&lt;/a&gt;&lt;/p&gt;
&lt;p&gt; The FDA is recommending that IND sponsors meet with the agency
at the end...&lt;/p&gt;
</description>
<link>http://www.pharmstatus.com/regulatory/archives/10-01-2008_10-31-2008.html#33</link>
<guid>http://www.pharmstatus.com/regulatory/archives/10-01-2008_10-31-2008.html#33</guid>

<category>guidelines</category>

<pubDate>Thu, 02 Oct 2008 14:05:10 -0700</pubDate>
</item>

<item>
<title>U.S. Food &amp; Drug Administration Approved the use of REYATAZ® (atazanavir sulfate) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients </title>
<description>
&lt;p&gt;&lt;a
href=&quot;http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&amp;amp;newsId=20081001006635&amp;amp;newsLang=en&quot;
 target=&quot;blank&quot;&gt;Business Wire Source&lt;/a&gt;&lt;/p&gt;
&lt;p&gt; Bristol-Myers Squibb Company (NYSE: BMY) announced today that
the U.S. Food &amp;amp; Drug...&lt;/p&gt;
</description>
<link>http://www.pharmstatus.com/regulatory/archives/10-01-2008_10-31-2008.html#32</link>
<guid>http://www.pharmstatus.com/regulatory/archives/10-01-2008_10-31-2008.html#32</guid>

<category>news</category>

<pubDate>Thu, 02 Oct 2008 14:01:04 -0700</pubDate>
</item>

<item>
<title>Process Validation Guidance to Focus on Testing Upfront</title>
<description>
&lt;p&gt;&lt;a target=&quot;blank&quot;
href=&quot;http://www.fdanews.com/newsletter/article?articleId=110237&amp;amp;issueId=11941&quot;&gt;FDA
News Source&lt;/a&gt;&lt;/p&gt;
&lt;p&gt; The FDA will emphasize more oversight and batch testing in the
early stages...&lt;/p&gt;
</description>
<link>http://www.pharmstatus.com/regulatory/archives/09-01-2008_09-30-2008.html#31</link>
<guid>http://www.pharmstatus.com/regulatory/archives/09-01-2008_09-30-2008.html#31</guid>

<category>guidelines</category>

<pubDate>Wed, 10 Sep 2008 17:22:20 -0700</pubDate>
</item>

<item>
<title>Prescription Drug Advertising Subject of New FDA Web Site for Consumers</title>
<description>
&lt;p&gt;&lt;a target=&quot;blank&quot;
href=&quot;http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&amp;amp;STORY=/www/story/09-05-2008/0004879743&amp;amp;EDATE=&quot;&gt;PR
News Wire Source&lt;/a&gt;&lt;/p&gt;
&lt;p&gt; EthicAd, a nonprofit organization devoted to improving public
health through consumer education,...&lt;/p&gt;
</description>
<link>http://www.pharmstatus.com/regulatory/archives/09-01-2008_09-30-2008.html#26</link>
<guid>http://www.pharmstatus.com/regulatory/archives/09-01-2008_09-30-2008.html#26</guid>

<category>news</category>

<pubDate>Fri, 05 Sep 2008 21:26:41 -0700</pubDate>
</item>

<item>
<title>FDA to List Drugs Under Review for Safety Issues</title>
<description>
&lt;p&gt;&lt;a target=&quot;blank&quot;
href=&quot;http://online.wsj.com/article/SB122063146959204277.html?mod=rss_whats_news_us_business&quot;&gt;Wall
Street Journal Source&lt;/a&gt; &lt;a target=&quot;blank&quot;
href=&quot;http://www.wave3.com/Global/story.asp?S=8961009&quot;&gt;Wave 3
Source&lt;/a&gt;&lt;/p&gt;
&lt;p&gt; Conference with Gerald...&lt;/p&gt;
</description>
<link>http://www.pharmstatus.com/regulatory/archives/09-01-2008_09-30-2008.html#24</link>
<guid>http://www.pharmstatus.com/regulatory/archives/09-01-2008_09-30-2008.html#24</guid>

<category>news</category>

<pubDate>Fri, 05 Sep 2008 21:16:05 -0700</pubDate>
</item>

</channel>
</rss>

